Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 2Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 33NIH 3NETWORK 2UNKNOWN 1OTHER_GOV 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 1

Interventions

Radiotherapy, Intensity-Modulated 3Radiotherapy 2Epirubicin 2Cytarabine 2pirarubicin 1durvalumab 1aclacinomycins 1Temozolomide 1Sorafenib 1Radiotherapy, Adjuvant 1Radiation Dose Hypofractionation 1Povidone-Iodine 1Pleurodesis 1Paclitaxel 1Nutrition Assessment 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Methylene Blue 1Indocyanine Green 1Equipment and Supplies 1Drug Therapy 1Doxorubicin 1Docetaxel 1Daunorubicin 1Cyclophosphamide 1Cabergoline 1CAG protocol 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × UNKNOWN × Docetaxel × Clear all
NCT05287308 2022-03-31

Adjuvant Albumin-bound Paclitaxel Versus Taxanes in Breast Cancer: a Real-world Study

ChineseAMS

Phase NA Not yet recruiting
500 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡